Can CBG Help With Pain Relief? What Current Research Shows

CBG is gaining attention as a possible option for pain relief. But does the research show that it actually works? So far, laboratory and animal studies have produced some encouraging findings, while human evidence remains limited. 

In this post, we will explain what CBG is, what researchers have found so far, and whether it is ready for pain management. We’ll also cover its legal status, current research limitations, and what the FDA says about products containing CBG.

If you are someone who always makes informed decisions, read the guide till the end so you can make a confident decision.

Quick Summary 

CBG has attracted researchers for its pain-relief properties, but the research is still in its initial stages. Early human research on CBG has begun, but it has not established CBG as a safe or effective long-term treatment for pain. A small study in healthy adults examined single oral doses, but it did not test whether CBG treats chronic pain.  So, patients already taking pain management medications should be careful about its use and consult with their doctor before adding it to their existing prescription. 

What Is CBG?

CBG is a short form of cannabigerol. It is found naturally in the cannabis plant and is also sometimes called a minor cannabinoid. The reason why researchers are taking interest in it is its association with several biological targets linked to pain, inflammation, and nerve signaling. 

According to a 2024 study, it is a compound that can interact with cannabinoid receptors and other signaling systems involved in this process. However, one thing that needs to be remembered about it is that it does not appear to produce the intoxicating effects associated with THC. That difference is what makes it an interesting compound for researchers.

How Is CBG Different from CBD and THC?

Whether it is CBG, CBD, or THC, they are all found in cannabis. However, they do not interact with your body in the same way. That’s why it is important to understand the difference between them. 

Below is a quick look at how these compounds differ from each other:

What Does the Research Show So Far?

Current evidence does not show that CBG reliably relieves pain in humans. Laboratory and animal studies suggest possible pain-related effects, but researchers still need larger human studies to determine whether CBG works for pain. 

Let’s go through the latest research about CBG in different areas.

Targeting Pain Signals

One of the strongest research findings is in pain signaling. Researchers have found that CBG can influence biological targets in pain signaling through the nervous system. 

They noticed it while they were testing CBG, CBD, and CBN against Nav1.8 in 2025. Their data showed that all three inhibited the channel, and CBG also reduced the excitability of sensory neurons.

Anti-Inflammatory Effects

Another key area of research is CBG’s anti-inflammatory properties. Inflammation can contribute to several forms of pain, so researchers have also looked at CBG’s effects on inflammatory pathways.

A 2025 study found that CBG affected inflammatory mediators through MAPK and NF-κB signaling in laboratory and mouse models. During the testing, oral CBG reduced expression of several inflammatory markers.

In fact, newer animal studies in 2026 have also reported analgesic and anti-inflammatory activity in experimental inflammatory pain. But again, all these studies are preclinical, so we cannot tell how well CBG would work for a person.

Receptor Interaction

CBG also interacts with several receptors and signaling systems. These include both CB2 and transient receptor potential channels. The evidence? A 2023 mouse study found that CBG affected TRPV1 and CB2-related pathways and reduced pain responses. The researchers studied it in inflammatory, arthritis, and nerve-pain models.

These findings give researchers useful clues about CBG’s potential for pain relief. However, that is only limited to animal research. They are still finding out how it will work in humans and whether it will show the same effects in patients with chronic pain or not.

Lack of Human Trials

Whenever it comes to establishing a medication as a reliable option, researchers have to perform well-controlled human trials at a larger scale. The clarity that comes from those trials gives them the ability to answer the most important questions, like the following ones:

• Is a particular drug really effective?
• Is its long-term use safe for humans?
• Which types of disorders suit it best?
• What should the ideal dose be? 

But in the case of CBG, researchers have just produced several interesting animal and laboratory findings. However, that does not mean human studies have not started yet. 

Instead, a recent human study involving 12 healthy adults examined oral CBG doses of 25 to 200 mg. The researchers found that CBG was generally well tolerated after acute dosing. At the same time, they also noted the need for longer-term studies.

So, until we have data from larger studies and clinical trials, people with painful conditions should wait and stay cautious.

What Types of Pain Are Researchers Studying CBG For?

There are different categories of pain under research in the current studies. Researchers are mainly looking to find the role of CBG in inflammatory and neuropathic pain. However, chemotherapy-induced peripheral neuropathy is also under consideration. Here is what they have found so far:

CBG for Nerve Pain

Neuropathic nerve pain starts when nerves or the systems that process nerve signals become damaged or altered. This type of pain may involve:

• Shooting
• Tingling
• Burning
• Strong response to touch

The good thing is that CBG has shown pain-reducing effects in several animal models of nerve pain. Currently, researchers are particularly interested in its effects on sensory neurons and channels such as Nav1.8.

Inflammatory Pain

The pain caused by inflammation is also a key area researchers are studying CBG for. Inflammatory pain usually occurs when immune activity causes tissue irritation and sensitizes pain pathways.

As mentioned earlier, CBG has shown anti-inflammatory and pain-related effects in some laboratory and animal studies. However, it should also be noted that results vary between models.

A 2024 study, for example, reveals that oral CBG did not prevent acute inflammatory pain in rats. That means researchers still need a wide variety of data before they reach any clinical conclusion. 

Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Besides inflammatory and neuropathic pain, CBG is also being studied for CIPN. Chemotherapy-induced peripheral neuropathy can cause painful sensitivity, tingling, and other nerve symptoms after cancer treatment. 

But when researchers tested it in 2023, they found that repeated CBG reduced mechanical hypersensitivity in male and female mice with cisplatin-induced neuropathy.

On the other hand, an independent 2024 study on mice, testing several minor cannabinoids, found that only CBN produced clear relief in its CIPN model. That means CBG did not show the same effect. These conflicting findings are limiting researchers from establishing CBG as a reliable pain reliever.

What Are the Biggest Limitations of Current CBG Research?

Research on CBG for pain remains too limited to support firm conclusions about its effectiveness in patients. While there are certain recent studies that show promising results, those findings are not applicable to humans. That is because there are different limitations in the current research. Here are the most notable ones among them:

• Most older studies, and even the current ones, have used cells or animals instead of people.
• There is no fixed dosage and preparation technique for CBG in different studies.
• Researchers are testing it for different types of pain, so there is no specified area yet.
• There is very limited data on whether CBG will perform safely in the long term or not.
• Researchers have not established a common CBG dose to treat pain.
• Studies have not clearly identified which patients would benefit most.

Be cautious when a CBG product claims to treat chronic pain or another medical condition. FDA has warned companies about marketing cannabis-derived products, including CBG products, with unapproved disease-treatment claims.

Is CBG Safe? What We Know About Side Effects and Drug Interactions

There is not enough human research to describe CBG’s long-term safety with confidence.

The recent healthy-adult dose study gives researchers some early human data, but 12 participants cannot reveal uncommon side effects or risks from months of use. So, people taking medications should be particularly careful.

Research has not established the full range of CBG drug interactions in humans. If you take prescription medication, discuss CBG with a qualified medical provider before adding it to your current regimen. 

The Final Words

So, does CBG help with pain relief? Possibly, but current evidence does not prove that CBG reliably treats pain in humans. So, if you were planning to combine it with your existing pain management medication, you should view it as just a research compound with potential benefit. 

However, if you are considering CBD or THC for chronic pain, you should speak with a qualified medical provider about your symptoms and current medications. Also, do not forget to talk about state requirements because medical cannabis is not legal in every state.

If you live in a state where medical cannabis certification applies, MedCert provides 100% online evaluations with licensed medical providers. Currently, we just offer online certification in New York and Virginia for a flat $79 fee through a secure telehealth process.